Literature DB >> 16595234

Endoscopic management of cesarean scar pregnancy.

Chin-Jung Wang1, An-Shine Chao, Leung-To Yuen, Chia-Wei Wang, Yung-Kuei Soong, Chyi-Long Lee.   

Abstract

OBJECTIVE: To describe our experiences with the diagnosis and endoscopic treatment of cesarean scar pregnancy.
DESIGN: Prospective clinical study.
SETTING: Tertiary care university hospital. PATIENT(S): Eleven women treated in our division between 1999 and 2004 who had been diagnosed with cesarean scar pregnancy. INTERVENTION(S): Transvaginal ultrasound was used for diagnosis, and endoscopy (laparoscopy and/or hysteroscopy) was used to treat cesarean scar pregnancy and preserve fertility. MAIN OUTCOME MEASURE(S): Operative blood loss, hospital stay, and time to resolution of serum beta-hCG were recorded. RESULT(S): The gestational age at diagnosis ranged between 6 and 11 weeks. Laparoscopic treatment was used in four women, hysteroscopic treatment in six women, and one woman underwent combined treatment with laparoscopy and hysteroscopy. The average blood loss during surgery was 110.9 mL (range, 20-300 mL), and average hospital stay was 1.7 days (range, 0.25-3 days). No complications occurred, and no blood transfusion was required. All patients' uteri were successfully preserved, and serum beta-hCG levels declined to a normal limit within 4 weeks postoperatively. CONCLUSION(S): When the diagnosis of cesarean scar pregnancy is made in the first trimester, endoscopy can be an alternative surgical treatment; the prognosis is good, and fertility can be preserved.

Entities:  

Mesh:

Year:  2006        PMID: 16595234     DOI: 10.1016/j.fertnstert.2005.07.1322

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  An application of uterine artery chemoembolization in treating cesarean scar pregnancy.

Authors:  Yan Huang; Youfei Li; Rongkai Xi; Zhengqiong Chen; Demei Ying; Zhen Li; Ying Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Cesarean Scar Pregnancy: Some Management Options.

Authors:  Chandrashekhar V Hegde
Journal:  J Obstet Gynaecol India       Date:  2017-04-11

3.  Injection of MTX for the treatment of cesarean scar pregnancy: comparison between different methods.

Authors:  Xiang-Hua Yin; Shi-Zhang Yang; Zhong-Qin Wang; Hong-Yan Jia; Min Shi
Journal:  Int J Clin Exp Med       Date:  2014-07-15

4.  Successful treatment of a repeat caesarean scar ectopic pregnancy with transvaginal intraamniotic instillation of methotrexate.

Authors:  Sharma Deepti; M G Usha; S Krishnadas
Journal:  J Obstet Gynaecol India       Date:  2012-08-17

5.  Management of a case of caesarean scar pregnancy and all its complications.

Authors:  Shuling Liu; Shivani Durai
Journal:  BMJ Case Rep       Date:  2016-05-17

6.  Conservative management of cesarean scar pregnancies: a prospective randomized controlled trial at a single center.

Authors:  Mingyi Wang; Zhiling Yang; Yunming Li; Biliang Chen; Jian Wang; Xiangdong Ma; Yu Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  Transvaginal hysterotomy for cesarean scar pregnancy in 40 consecutive cases.

Authors:  Zhang Huanxiao; Chen Shuqin; Jiang Hongye; Xie Hongzhe; Niu Gang; Xu Chengkang; Guan Xiaoming; Yao Shuzhong
Journal:  Gynecol Surg       Date:  2014-10-22

8.  High-intensity focused ultrasound combined with suction curettage for the treatment of cesarean scar pregnancy.

Authors:  Xiaogang Zhu; Xinliang Deng; Yajun Wan; Songshu Xiao; Jiping Huang; Lian Zhang; Min Xue
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

9.  Laparoscopic treatment of placenta percreta retention in a cesarean scar: a case report.

Authors:  Jean-Bernard Dubuisson; Nordine Ben Ali; Jean Bouquet de Jolinière; Manuela Haggenjos; Anis Feki
Journal:  Front Surg       Date:  2014-03-24

10.  Laparoscopic management or laparoscopy combined with transvaginal management of type II cesarean scar pregnancy.

Authors:  Huan-Ying Wang; Jun Zhang; Yan-Na Li; Wei Wei; Da-Wei Zhang; Yu-Qiu Lu; Hao-Feng Zhang
Journal:  JSLS       Date:  2013 Apr-Jun       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.